RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Michelle M. Martinez-Montemayor and Ivette J. Suarez-Arroyo.
  1. Su?rez-Arroyo IJ, Loperena-Alvarez Y, Rosario-Acevedo R, Mart?nez-Montemayor MM. Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer. Medicines (Basel). 2017 Mar; 4(1).
    View in: PubMed
    Score: 0.596
  2. Su?rez-Arroyo IJ, Feliz-Mosquea YR, P?rez-Laspiur J, Arju R, Giashuddin S, Maldonado-Mart?nez G, Cubano LA, Schneider RJ, Mart?nez-Montemayor MM. The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease. Am J Cancer Res. 2016; 6(8):1720-40.
    View in: PubMed
    Score: 0.571
  3. Su?rez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alviarez DJ, Maldonado-Martinez G, Cubano LA, Mart?nez-Montemayor MM. Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. J Cancer. 2016; 7(5):500-11.
    View in: PubMed
    Score: 0.552
  4. Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Mart?nez-Montemayor MM. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. PLoS One. 2013; 8(2):e57431.
    View in: PubMed
    Score: 0.451
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support